MADRID, June 23, 2017 /PRNewswire/ --
Hemorrhagic and thrombocytopenic patients require platelet transfusion to preventor treat bleeding. Cold storage of platelets results in complex molecular lesions associated with changes in platelet membrane microdomains that are recognized by host macrophages and hepatocyte counter-receptors, resulting in phagocytosis and clearance
(Logo: http://mma.prnewswire.com/media/524821/EHA_Logo.jpg )
Presenter: Dr Shailaja Hegde
Affiliation: Cincinnati Children's Hospital Medical Center & Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Topic: REVERSIBLE PHARMACOLOGICAL TARGETING OF RHOA PREVENTS REFRIGERATED PLATELET STORAGE LESION ALLOWING NORMAL SURVIVAL AND HEMOSTATIC ACTIVITY OF PLATELETS IN VITRO AND IN VIVO, IN MICE AND IN PRIMATES
Abstract S149 will be presented by Shailaja Hegde on Friday, June 23 15:45 - 17:00 in Hall A.
About the EHA Annual Congress Hematology is a specialty that covers everything to do with blood: its origin in the bone marrow, diseases of blood and their treatments. The latest data on research and developments will be presented. The topics range from stem cell physiology and development, to leukemia, lymphoma, myeloma - diagnosis and treatment; red blood cells -, white blood cells- and platelet disorders; thrombosis and bleeding disorders.
SOURCE European Hematology Association
Subscribe to our Free Newsletters!
Malaria is a dangerous disease with lethal consequences that requires protective measures for ...
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ...
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...View All